Abstract:Matrix metalloproteinases are involved in a complex multifactorial process of atherosclerotic plaque formation and play a leading role in the degradation of the extracellular matrix components and increase the migratory activity of cellular elements of the vascular wall. Despite a number of scientific studies, it is necessary to identify clear biochemical markers for the development of atherosclerotic lesions. The purpose of the study was to investigate the relationship between the activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in myocardial homogenate with changes of the cells composition in the coronary arteries wall in experimental atherosclerosis. Materials and methods. The studies were performed on 76 nonlinear rats, which were divided into 3 groups: group Ia was the control (n=20) – animals, injected intracutaneously with 0.1 ml of 0.9 % sodium chloride solution; Ib – comparison group (n=20) – animals injected with incomplete Freund’s adjuvant at the dose of 0.1 ml intracutaneously and II – experimental group (n=36), which were immunized with native human low-density lipoprotein at a single dose of 200 μg, diluted in 0.1 ml of incomplete Freund’s adjuvant, regardless of the weight. The experiment lasted for 20 weeks. Material sampling was performed, starting from the 4th week after the drug administration. From the coronary arteries and the adjacent myocardium, microslides were made according to the generally accepted technique, which were stained with hematoxylin and eosin, according to the methods of Van Gizon, Mallory and Sudan III. The activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 was determined by enzyme-zimografic method. Results and discussion. The growth of matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in atherosclerotic lesions showed stages of degradation of extracellular matrix components: the dynamics of matrix metalloproteinase-2 activity during the experiment increased from 109.1±1.23 % at the 12th week to 127.32±0.99 % at the 20th week. The increased activity of matrix metalloproteinase-2 was associated with an increase in the number of leukocytes and macrophages, including foam cells. The activity of matrix metalloproteinase-9 reached the highest values of 98.24±0.82% at the 8th period from the onset of changes to the final level of 86.26±0.54% at the maximum terms of the experiment. Conclusion. The growing activity of matrix metalloproteinase-9 indicated the development of early atherosclerotic lesions, while the high level of activity of matrix metalloproteinase-2 indicated significant structural changes in the wall of the coronary arteries

Vascular Extracellular Matrix in Atherosclerosis

Vascular Fibrosis in Atherosclerosis

Extracellular Matrix Interactome in Modulating Vascular Homeostasis and Remodeling

ECM Microenvironment in Vascular Homeostasis: New Targets for Atherosclerosis

Optical Metrics of the Extracellular Matrix Predict Compositional and Mechanical Changes after Myocardial Infarction.

Vascular wall extracellular matrix proteins and vascular diseases

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

The Extracellular Matrix in Ischemic and Nonischemic Heart Failure

Extracellular matrix dynamics in vascular remodeling

The Role of Matrix Proteins in Cardiac Pathology

Vascular Extracellular Matrix Remodeling and Hypertension

Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering

The extracellular matrix mechanics in the vasculature

Role of the extracellular matrix in cell–cell communication: a new therapeutic target?

Matrix stiffness, endothelial dysfunction and atherosclerosis

Collagens and atherosclerosis

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.

Relationship between the Activity of Matrix Metalloproteinase-2 and -9 in Myocardial Homogenate with Changes of the Cells Composition in the Coronary Arteries Wall in the Experiment

Engineering Smooth Muscle to Understand Extracellular Matrix Remodeling and Vascular Disease

Extracellular matrix remodeling and cardiac fibrosis

Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review